Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 28 , ISSUE 11 ( November, 2024 ) > List of Articles

PEDIATRIC CRITICAL CARE MEDICINE

Role of Intravenous Dexamethasone in Prevention of Postextubation Airway Obstruction in Mechanically Ventilated Children in Pediatric Intensive Care Unit: A Double-blind Randomized Controlled Trial

Anjali R Varghese, Pratyusha Kambagiri, Manas R Sahoo, Atul Jindal, Anil K Goel

Keywords : Dexamethasone, Mechanical ventilation, Pediatric intensive care unit, Postextubation airway obstruction, Stridor score

Citation Information : Varghese AR, Kambagiri P, Sahoo MR, Jindal A, Goel AK. Role of Intravenous Dexamethasone in Prevention of Postextubation Airway Obstruction in Mechanically Ventilated Children in Pediatric Intensive Care Unit: A Double-blind Randomized Controlled Trial. Indian J Crit Care Med 2024; 28 (11):1063-1068.

DOI: 10.5005/jp-journals-10071-24830

License: CC BY-NC 4.0

Published Online: 30-10-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Objective: To study the efficacy of intravenous dexamethasone in preventing postextubation airway obstruction (PEAO). Design: A double-blinded randomized controlled trial. Study setting: The study was conducted in level 3 PICU at AIIMS, Raipur, India, from December 2019 to September 2022. Subjects: Children requiring intubation for at least 24 hours and not beyond 14 days were included. Children with upper airway anomalies or who received corticosteroids within the last 7 days were excluded. Intervention: The children who satisfied the inclusion criteria were randomized into dexamethasone or placebo group by stratified variable block randomization. Dexamethasone (0.5 mg/kg/dose) or placebo was given four doses (–12 hr., –6 hr., 0 hr., and 6 hr. of extubation). Outcome: The occurrence of any clinically significant stridor (Westley stridor score ≥3) was the primary outcome. Measurements and main results: Of the seventy (n = 70) children included in the study, 35 received dexamethasone while 35 received placebo. Westley stridor score ≥3 was present in 25.71% (n = 9) in dexamethasone group vs 31.42% (n = 11) in placebo (p = 0.792). Reintubation occurred in 14.28% (n = 10/70) patients, 11.42% (4/35) in dexamethasone group, and 17.14% (6/35) in placebo group (p = 0.734). Five children in the dexamethasone group and six in placebo group died (p = 1.00). There was no difference in the length of PICU stay (p = 0.84) and hospital stay (p = 0.75) among both the groups. Conclusion: Administration of multiple doses of dexamethasone may not help in the prevention of reintubation but may help in the reducing the incidence of clinically significant stridor.


PDF Share
  1. Thomas R, Kumar EV, Kameswaran M, Shamim A, Al Ghamdii S, Mummigatty AP, et al. Post intubation laryngeal sequelae in an intensive care unit. J Laryngol Otol 1995;109(4):313–316. DOI: 10.1017/S0022215100130002.
  2. Hartley M, Vaughan RS. Problems associated with tracheal extubation. BJA Br J Anaesth 1993;71(4):561–568. DOI: 10.1093/bja/71.4.561.
  3. Fan L, Flynn J, Pathak D, Graves SA. Risk factors predicting laryngeal injury in intubated neonates. Surv Anesthesiol 1984;28(6):117. DOI: 10.1097/00003246-198306000-00007.
  4. Whited RE. A prospective study of laryngotracheal sequelae in long-term intubation. The Laryngoscope 1984;94(3):367–377. DOI: 10.1288/00005537-198403000-00014.
  5. Rivera R, Tibballs J. Complications of endotracheal intubation and mechanical ventilation in infants and children. Crit Care Med 1992;20(2):193–199. DOI: 10.1097/00003246-199202000-00008.
  6. Santos PM, Afrassiabi A, Weymuller Jr EA. Risk factors associated with prolonged intubation and laryngeal injury. Otolaryngol Neck Surg 1994;111(4):453–459. DOI: 10.1177/019459989411100411.
  7. Tadié JM, Behm E, Lecuyer L, Benhmamed R, Hans S, Brasnu D, et al. Post-intubation laryngeal injuries and extubation failure: A fiberoptic endoscopic study. Intensive Care Med 2010;36(6):991–998. DOI: 10.1007/s00134-010-1847-z.
  8. Anene O, Meert KL, Uy H, Simpson P, Sarnaik AP. Dexamethasone for the prevention of postextubation airway obstruction: A prospective, randomized, double-blind, placebo-controlled trial. Crit Care Med 1996;24(10):1666–1669. DOI: 10.1097/00003246-199610000-00011.
  9. Pender JW. Endotracheal anesthesia in children: Advantages and disadvantages. In: J Am Soc Anesthesiol. Am Soc Anesthesiol 1954;15(5):495–506. DOI: 10.1097/00000542-195409000-00009.
  10. Meade MO, Guyatt GH, Cook DJ, Sinuff T, Butler R. Trials of corticosteroids to prevent postextubation airway complications. Chest 2001;120(6):464S–468S. DOI: 10.1378/chest.120.6_suppl.464S.
  11. Ajith Kumar AK, Cascella M. Post intubation laryngeal edema. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
  12. Shaikh F, Chirla D, Janaapureddy YR, Mohanty S, Reddy PK, Sachane K, et al. Utility of Endotracheal tube cuff pressure monitoring in mechanically ventilated (MV) children in preventing post-extubation stridor (PES). Indian J Crit Care Med 2021;25(2):181–184. DOI: 10.5005/jp-journals-10071-23737.
  13. Deming MV, Oech SR. Steroid and antihistaminic therapy for post intubation subglottic edema in infants and children. In: J Am Soc Anesthesiol. Am Soc Anesthesiol 1961;22(6):933–936. DOI: 10.1097/00000542-196111000-00011.
  14. Jordan WS, Graves CL, Elwyn RA. New therapy for postintubation laryngeal tracheitis in children edema. JAMA 1970;212(4):585–588. DOI: 10.1001/jama.1970.03170170031005.
  15. Sinha A, Jayashree M, Singhi S. Aerosolized L-epinephrine vs budesonide for post extubation stridor: A randomized controlled trial. Indian Pediatr 2010;47(4):317–322. DOI: 10.1007/s13312-010-0060-z.
  16. Freezer N, Butt W, Phelan P. Steroids in croup: Do they increase the incidence of successful extubation? Anaesth Intensive Care 1990;18(2):224–228. DOI: 10.1177/0310057X9001800212.
  17. Kashefi P, Abbasi A, Abbasi M, Davoodi L, Abbasi S. Comparison of the efficacy of nebulized budesonide and intravenous dexamethasone administration before extubation in prevention of post-extubation complications among patients admitted in intensive care unit. Adv Biomed Res 2015;4(1):11. DOI: 10.4103/2277-9175.148293.
  18. Lukkassen IMA, Hassing MBF, Markhorst DG. Dexamethasone reduces reintubation rate due to postextubation stridor in a high-risk paediatric population. Acta Paediatr Oslo Nor 1992 2006;95(1):74–76. DOI: 10.1080/08035250500325066.
  19. Malhotra D, Gurcoo S, Qazi S, Gupta S. Randomized comparative efficacy of dexamethasone to prevent postextubation upper airway complications in children and adults in ICU. Indian J Anaesth 2009;53(4):442–449. PMID: 20640206.
  20. Lee CH, Peng MJ, Wu CL. Dexamethasone to prevent postextubation airway obstruction in adults: A prospective, randomized, double-blind, placebo-controlled study. Crit Care Lond Engl 2007;11(4):R72. DOI: 10.1186/cc5957.
  21. Ferrara TB, Georgieff MK, Ebert J, Fisher JB. Routine use of dexamethasone for the prevention of postextubation respiratory distress. J Perinatol Off J Calif Perinat Assoc 1989;9(3):287–290. PMID: 2809781.
  22. Jansaithong J. The use of dexamethasone in the prevention of postextubation stridor in pediatric patients in PICU/NICU settings: An analytical review. J Soc Pediatr Nurses JSPN 2001;6(4):182–191. DOI: 10.1111/j.1744-6155.2001.tb00242.x.
  23. Khemani RG, Randolph A, Markovitz B. Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults. Cochrane Airways Group, editor. Cochrane Database Syst Rev 2009;2014(6). DOI: 10.1002/14651858.CD001000.pub3.
  24. Kimura S, Ahn JB, Takahashi M, Kwon S, Papatheodorou S. Effectiveness of corticosteroids for post-extubation stridor and extubation failure in pediatric patients: A systematic review and meta-analysis. Ann Intensive Care 2020;10(1):155. DOI: 10.1186/s13613-020-00773-6.
  25. Ritu, Jhamb U. Dexamethasone in prevention of postextubation stridor in ventilated children: A randomized, double-blinded, placebo-controlled trial. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med 2020;24(12):1230–1235. DOI: 10.500/jp-journals-10071-23679.
  26. Iyer NP, López-Fernández YM, González-Dambrauskas S, Baranwal AK, Hotz JC, Zhu M, et al. A network meta-analysis of dexamethasone for preventing postextubation upper airway obstruction in children. Ann Am Thorac Soc. Am Thorac Soc 2023;20(1):118–130. DOI: 10.1513/AnnalsATS.202203-212OC.
  27. Butragueño-Laiseca L, Manrique Martín G, González Cortés R, Rey Galán C, Martínez De Compañón Martínez De Ma Z, Gil Antón J, et al. Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children. Sci Rep 2022;12(1):4336. DOI: 10.1038/s41598-022-08178-0.
  28. Baranwal AK, Meena JP, Singhi SC, Muralidharan J. Dexamethasone pretreatment for 24 h versus 6 h for prevention of postextubation airway obstruction in children: A randomized double-blind trial. Intensive Care Med 2014;40(9):1285–1294. DOI: 10.1007/s00134-014-3358-9.
  29. Fontela PS, Piva JP, Garcia PC, Bered PL, Zilles K. Risk factors for extubation failure in mechanically ventilated pediatric patients. Pediatr Crit Care Med 2005;6(2):166–170. DOI: 10.1097/01.PCC.0000154922.65189.48.
  30. Harel Y, Vardi A, Quigley R, Brink LW, Manning SC, Carmody TJ, et al. Extubation failure due to post-extubation stridor is better correlated with neurologic impairment than with upper airway lesions in critically ill pediatric patients. Int J Pediatr Otorhinolaryngol 1997;39(2):147–158. DOI: 10.1016/S0165-5876(97)01488-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.